Product Images Depo-provera

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Depo-provera NDC 0009-0746 by Pharmacia & Upjohn Company Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - depo provera 01

Figure 1 - depo provera 01

The document displays a table of odds ratios (with accompanying 95% confidence intervals) obtained from five studies investigating the relationship between long-term use of DMPA (a contraceptive injection) and the risk of developing a specific health condition. The data is presented in logarithmic scale, with each row representing a different study and each column representing a different level of DMPA use. The last row displays the overall odds ratio for all subjects. Odds ratios greater than 1 indicate an increased risk for DMPA use, while odds ratios less than 1 indicate a decreased risk. No information is given about the health condition being investigated, and there is no accompanying text.*

Chemical Structure - depo provera 02

Chemical Structure - depo provera 02

Logo - depo provera 03

Logo - depo provera 03

Chart - depo provera 03a

Chart - depo provera 03a

This text appears to be a chart or table regarding different methods of birth control and their effectiveness rates in preventing pregnancy over the course of one year. It lists different methods, such as injections, intrauterine devices, sterilization, birth control pills, condoms, and others, along with their effectiveness rates in terms of number of pregnancies per 100 women. It also includes a section on natural methods of birth control, such as avoiding sex during the most fertile days of the monthly cycle and withdrawal.*

depo provera 03b

depo provera 03b

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Label - depo provera 04

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Label - depo provera 04

This appears to be a product label for the contraceptive injection Depo-Provera® by Pharmacia & Upjohn Co. It provides instructions on the dosage and use of the medication, specifying that it is for intramuscular use only. The label also includes the National Drug Code and Rx only information. It advises shaking the bottle before use and storing it upright as a table suspension. However, the last line "ikt 150 ma/m" is not clear and its meaning is not available.*

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Carton - depo provera 05

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Carton - depo provera 05

This product is a contraceptive injection called Depo-Provera. The dosage and use details are available in the accompanying prescribing information. Vials of this injection must be stored upright at a controlled room temperature of 20-25°C. The injection contains medroxyprogesterone acetate and is available in a single-dose vial for intramuscular use only. The label also includes the lot number, expiration date, and serial number. However, further details about the usage and precautions need to be consulted before taking this injection.*

Principal Display Panel - 1 mL Syringe Label - depo provera 06

Principal Display Panel - 1 mL Syringe Label - depo provera 06

Depo-Provera® is a contraceptive injection consisting of 150 mg/mL of medroxyprogesterone acetate in an injectable suspension for intramuscular use only. It is dispensed in a single-dose syringe and requires shaking before use. It is manufactured by Pfizer Inc. The lot number indicated is 802671.*

Principal Display Panel - 1 mL Syringe Carton - depo provera 07

Principal Display Panel - 1 mL Syringe Carton - depo provera 07

Depo-Provera is a contraceptive injection that contains medroxyprogesterone acetate. The injection is provided in a 1 mL prefilled syringe and is for intramuscular use only. The recommended storage temperature is between 20° to 25°C, and the injection should be shaken vigorously before use. The syringe comes with a protective cap that must be removed before usage. The medication should be discarded appropriately after use, and the syringe should not be reused for safety reasons. The text also includes details about the preparation of the syringe and other information such as trademarks, manufacturer details, and GTI/LOTEXP/SH codes.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.